XORTX Therapeutics Inc Strategic Asset Allocation Index
XORTX Therapeutics Inc strategic asset allocation index. XORTX Therapeutics Inc (XRTX) has a Strategic Asset Allocation Index of 1.3% as of December 2022. Strategic assets (PP&E of CA$125.53K plus long-term investments of CA$-) total CA$125.53K, measured against net assets of CA$9.47 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See XORTX Therapeutics Inc balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of XORTX Therapeutics Inc (2018–2022)
Strategic asset allocation index of XORTX Therapeutics Inc from 2018 to 2022. This chart shows how XORTX Therapeutics Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2018 to 2022. As of December 2022, the index stands at 1.3%, representing strategic assets of CA$125.53K against net assets of CA$9.47 Million CAD. Check how tangible is XORTX Therapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
XORTX Therapeutics Inc Strategic Asset Allocation Index by Year (2018–2022)
XORTX Therapeutics Inc strategic asset allocation index by year from 2018 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for XORTX Therapeutics Inc from 2018 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see XORTX Therapeutics Inc (XRTX) market capitalisation.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.8% | CA$125.53K | CA$125.53K | CA$- | CA$6.97 Million | ▲ +1.6 pp |
| 2018 | 0.2% | CA$731.00 | CA$731.00 | CA$- | CA$321.54K | — |